Inventor
MOEHLER HANNS
CH15 patents
⚠️ This page may combine multiple inventors who share the name “MOEHLER HANNS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
10 patentsUS4316839AFeb 23, 1982
Imidazodiazepine derivatives
HOFFMANN LA ROCHE70 citations96
US4359420ANov 16, 1982
Thieno-1,4-diazepin-5-ones and benzo-1,4-diazepin-5-ones
HOFFMANN LA ROCHE11 citations81
US4363762ADec 14, 1982
Process for preparing imidazodiazepines
HOFFMANN LA ROCHE4 citations73
US4346033AAug 24, 1982
Thienodiazepinone and benzodiazepinone intermediates
HOFFMANN LA ROCHE3 citations73
US4346036AAug 24, 1982
Process for preparing imidazodiazepine derivatives
HOFFMANN LA ROCHE4 citations73
US4346030AAug 24, 1982
Imidazodiazepine derivatives
HOFFMANN LA ROCHE6 citations73
US4346034AAug 24, 1982
Process for preparing imidazodiazepines
HOFFMANN LA ROCHE4 citations73
US4346031AAug 24, 1982
Process for preparing imidazodiazepines
HOFFMANN LA ROCHE4 citations73
US4346032AAug 24, 1982
Imidazodiazepine derivatives
HOFFMANN LA ROCHE4 citations73
US4346035AAug 24, 1982
Process for preparing imidazodiazepines
HOFFMANN LA ROCHE4 citations73
GEISTLICH PHARMA AG
4 patentsUS11999709B2Jun 4, 2024
Processes for preparing oxathiazin-like compounds
GEISTLICH PHARMA AG2 citations73
US11591302B2Feb 28, 2023
Processes for preparing oxathiazin-like compounds
GEISTLICH PHARMA AG3 citations73
US12534443B2Jan 27, 2026
Processes for preparing oxathiazin-like compounds
GEISTLICH PHARMA AG0 citations62
US12514847B2Jan 6, 2026
Oxathiazin_dioxide for treating, preventing, inhibiting or reducing cytokine release
GEISTLICH PHARMA AG0 citations61